Table 1.
Figure | Group | Total Number of Animals Used |
Sample Size | Number of Animals Excluded 1 |
|
---|---|---|---|---|---|
Figure 1B | Butoxamine concentration (mg/kg) |
||||
Control | 0 | 16 | 14 | 2 | |
30 | 6 | 6 | 0 | ||
AcGP | 0 | 18 | 18 | 0 | |
3 | 4 | 4 | 0 | ||
10 | 8 | 7 | 1 | ||
30 | 9 | 9 | 0 | ||
Figure 1C | Carazolol concentration (mg/kg) |
||||
Control | 0 | 12 | 12 | 0 | |
10 | 8 | 8 | 0 | ||
AcGP | 0 | 12 | 12 | 0 | |
0.3 | 8 | 8 | 0 | ||
1 | 8 | 8 | 0 | ||
10 | 8 | 8 | 0 | ||
Figure 1E | Butoxamine concentration (mg/kg) |
||||
Control | 0 | 5 | 5 | 0 | |
30 | 6 | 6 | 0 | ||
AcGP | 0 | 5 | 5 | 0 | |
30 | 6 | 6 | 0 | ||
Figure 1F | Carazolol concentration (mg/kg) |
||||
Control | 0 | 6 | 6 | 0 | |
10 | 7 | 6 | 1 | ||
AcGP | 0 | 6 | 6 | 0 | |
10 | 6 | 6 | 0 | ||
Figure 2A | Prazosin concentration (mg/kg) |
||||
Control | 0 | 8 | 8 | 0 | |
10 | 8 | 8 | 0 | ||
AcGP | 0 | 8 | 8 | 0 | |
1 | 4 | 4 | 0 | ||
10 | 8 | 8 | 0 | ||
Figure 2B | Butylscopolamine concentration (mg/kg) |
||||
Control | 0 | 8 | 8 | 0 | |
15 | 4 | 4 | 0 | ||
AcGP | 0 | 8 | 8 | 0 | |
5 | 4 | 4 | 0 | ||
15 | 4 | 4 | 0 | ||
Figure 3B | Butoxamine concentration (mg/kg) |
||||
Control | 0 | 8 | 8 | 0 | |
30 | 8 | 8 | 0 | ||
AcGP | 0 | 8 | 8 | 0 | |
30 | 9 | 8 | 1 | ||
Figure 3C | Prazosin concentration (mg/kg) |
||||
Control | 0 | 7 | 7 | 0 | |
10 | 8 | 8 | 0 | ||
AcGP | 0 | 8 | 8 | 0 | |
10 | 8 | 8 | 0 |
1 Animals which died at the time of drug injection or anesthesia were excluded.